“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Evidence-Based Psychopharmacology

Evidence-Based Psychopharmacology Evidence-Based Psychopharmacology There is an initial introduction that is not a numbered chapter, explaining the aims of the book and defining evidence-based medicine and its history. This is followed by 11 chapters, written by 1 or more of 29 additional authors. These are organized by psychiatric disorder. There is a final, twelfth chapter that deals specifically with medication interactions. Not all psychiatric diagnoses are covered, but those with the highest likelihood of response to pharmacologic interventions have a full chapter devoted to them: major depression, bipolar disorder, schizophrenia, generalized anxiety, panic, posttraumatic stress, social anxiety disorder, eating disorders, attention-deficit disorder, and Alzheimer's disease. Following a brief introduction to each disorder, including such things as epidemiology, subtypes, co-morbidities, and other such information, the authors tackle the following basic treatment issues: What is the first-line psychopharmacologic approach? How long a trial at what dose should the practitioner give a specific medication? What is the next best alternative if first-line treatment fails? Different chapters do this in somewhat varying styles, depending on how well the disorder lends itself to such dissection and the authors' approach, but each chapter addresses these basic issues in one form or another and ends with a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Informa Healthcare

Evidence-Based Psychopharmacology

Abstract

Evidence-Based Psychopharmacology There is an initial introduction that is not a numbered chapter, explaining the aims of the book and defining evidence-based medicine and its history. This is followed by 11 chapters, written by 1 or more of 29 additional authors. These are organized by psychiatric disorder. There is a final, twelfth chapter that deals specifically with medication interactions. Not all psychiatric diagnoses are covered, but those with the highest likelihood of response to pharmacologic interventions have a full chapter devoted to them: major depression, bipolar disorder, schizophrenia, generalized anxiety, panic, posttraumatic stress, social anxiety disorder, eating disorders, attention-deficit disorder, and Alzheimer's disease. Following a brief introduction to each disorder, including such things as epidemiology, subtypes, co-morbidities, and other such information, the authors tackle the following basic treatment issues: What is the first-line psychopharmacologic approach? How long a trial at what dose should the practitioner give a specific medication? What is the next best alternative if first-line treatment fails? Different chapters do this in somewhat varying styles, depending on how well the disorder lends itself to such dissection and the authors' approach, but each chapter addresses these basic issues in one form or another and ends with a
Loading next page...
 
/lp/informa-healthcare/evidence-based-psychopharmacology-EPotAWM9Wh

Sorry, we don't have permission to share this article on DeepDyve,
but here are related articles that you can start reading right now: